Melbourne, Nov 20, 2008 (ABN Newswire) - Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that it has, with immediate effect, implemented steps to further reduce its cash burn. These measures are designed to guarantee that the Company maintains sufficient funding to finance its near term key activities including ongoing negotiations with CSIRO, IP prosecution and maintenance and the City of Hope collaboration.
